首页> 外文期刊>Child Neurology Open >Childhood-Onset Progressive Dystonia With Mitochondrial DNA G14459A Mutation: Efficacy of Long-Term Sodium Succinate Treatment
【24h】

Childhood-Onset Progressive Dystonia With Mitochondrial DNA G14459A Mutation: Efficacy of Long-Term Sodium Succinate Treatment

机译:线粒体DNA G14459A突变的儿童发作性肌张力障碍:长期琥珀酸钠治疗的功效。

获取原文
           

摘要

This article reports the case of an 11-year-old boy with progressive dystonia caused by the homoplasmic G14459A mitochondrial DNA mutation. The patient presented with focal dystonia in the right upper limb at 3 years of age, which progressed over 4 years to exhibit dystonia in both the upper and lower limbs. At 7 years of age, high signal intensity lesions in the bilateral striata and the midbrain were observed on fluid-attenuated inversion recovery images. It was observed on diffusion-weighted images that with time, these high signal intensity lesions migrated from the putamen to the caudate nuclei, which closely correlated with disease progression. Because his symptoms and abnormal magnetic resonance imaging findings progressed despite treatment with coenzyme Q10 and l-carnitine, at 7 years of age he was then started on sodium succinate, hoping to improve his complex I deficiency. After treatment, progression of MRI abnormalities appeared to have been suppressed for 4 years, although no improvement was observed in dystonia.
机译:本文报道了由同质G14459A线粒体DNA突变引起的进行性肌张力障碍的11岁男孩的病例。该患者3岁时右上肢出现局灶性肌张力障碍,经过4年的发展,上肢和下肢均出现肌张力障碍。在7岁时,在液体衰减的反转恢复图像上观察到了双侧纹状体和中脑的高信号强度病变。在弥散加权图像上观察到,随着时间的流逝,这些高信号强度病变从核壳迁移到尾状核,这与疾病的进展密切相关。尽管使用辅酶Q10和左旋肉碱进行治疗,但由于他的症状和异常的磁共振成像发现仍在发展,所以他在7岁时开始使用琥珀酸钠,以改善其复杂的I缺乏症。治疗后,尽管肌张力障碍未见改善,但MRI异常的进展似乎已被抑制了4年。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号